Using Molecular Initiating Events To Generate 2D Structure-Activity Relationships for Toxicity Screening

被引:12
作者
Allen, Timothy E. H. [1 ]
Liggi, Sonia [1 ]
Goodman, Jonathan M. [1 ]
Gutsell, Steve [2 ]
Russell, Paul J. [2 ]
机构
[1] Univ Cambridge, Dept Chem, Ctr Mol Informat, Lensfield Rd, Cambridge CB2 1EW, England
[2] Unilever Safety & Environm Assurance Ctr, Colworth Sci Pk, Sharnbrook MK44 1LQ, Beds, England
关键词
MUSCARINIC ACETYLCHOLINE-RECEPTOR; HISTONE DEACETYLASE INHIBITORS; OUTCOME PATHWAY FRAMEWORK; CRYSTAL-STRUCTURE; ANDROGEN RECEPTOR; DOPAMINE TRANSPORTER; POTASSIUM CHANNEL; MONOAMINE-OXIDASE; HUMAN-PLATELETS; RISK-ASSESSMENT;
D O I
10.1021/acs.chemrestox.6b00101
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Molecular initiating events (MIEs) can be boiled down to chemical interactions. Chemicals that interact must have intrinsic properties that allow them to exhibit this behavior, be these properties stereochemical, electronic, or otherwise. In an attempt to discover some of these chemical characteristics, we have constructed structural alert-style structure activity relationships (SARs) to computationally predict MIEs. This work utilizes chemical informatics approaches, searching the ChEMBL database for molecules that bind to a number of pharmacologically important human toxicology targets, including G-protein coupled receptors, enzymes, ion channels, nuclear receptors, and transporters. By screening these compounds to find common 2D fragments and combining this approach with a good understanding of the literature, bespoke 2D structural alerts have been written. These SARs form the beginning of a tool for screening novel chemicals to establish the kind of interactions that they may be able to make in humans. These SARs have been run through an internal validation to test their quality, and the results of this are also discussed. MIEs have proven to be difficult to find and characterize, but we believe we have taken a key first step with this work.
引用
收藏
页码:1611 / 1627
页数:17
相关论文
共 78 条
[1]  
Accelrys Software Inc, PIP PIL V 8 0 1 500
[2]   Mechanisms of Neuroprotective Effects of Nicotine and Acetylcholinesterase Inhibitors: Role of α4 and α7 Receptors in Neuroprotection [J].
Akaike, Akinori ;
Takada-Takatori, Yuki ;
Kume, Toshiaki ;
Izumi, Yasuhiko .
JOURNAL OF MOLECULAR NEUROSCIENCE, 2010, 40 (1-2) :211-216
[3]   Defining Molecular Initiating Events in the Adverse Outcome Pathway Framework for Risk Assessment [J].
Allen, Timothy E. H. ;
Goodman, Jonathan M. ;
Gutsell, Steve ;
Russell, Paul J. .
CHEMICAL RESEARCH IN TOXICOLOGY, 2014, 27 (12) :2100-2112
[4]   Acute effects of the oral administration of midodrine, an α-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites [J].
Angeli, P ;
Volpin, R ;
Piovan, D ;
Bortoluzzi, A ;
Craighero, R ;
Bottaro, S ;
Finucci, GF ;
Casiglia, E ;
Sticca, A ;
De Toni, R ;
Pavan, L ;
Gatta, A .
HEPATOLOGY, 1998, 28 (04) :937-943
[5]   ADVERSE OUTCOME PATHWAYS: A CONCEPTUAL FRAMEWORK TO SUPPORT ECOTOXICOLOGY RESEARCH AND RISK ASSESSMENT [J].
Ankley, Gerald T. ;
Bennett, Richard S. ;
Erickson, Russell J. ;
Hoff, Dale J. ;
Hornung, Michael W. ;
Johnson, Rodney D. ;
Mount, David R. ;
Nichols, John W. ;
Russom, Christine L. ;
Schmieder, Patricia K. ;
Serrrano, Jose A. ;
Tietge, Joseph E. ;
Villeneuve, Daniel L. .
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2010, 29 (03) :730-741
[6]  
[Anonymous], 2007, TOXICOLOGY TESTING 2
[7]  
[Anonymous], PHARM BIOCH BEHAV, V105, P41
[8]  
[Anonymous], CHEMBL DAT
[9]  
[Anonymous], 2012, Proposal for a Template and Guidance on Developing and Assessing the Completeness of Adverse Outcome Pathways
[10]  
ARNSTEN AFT, 1988, J NEUROSCI, V8, P4287